Designer Drug, 25D-NBOMe, Has Reinforcing and Rewarding Effects through Change of a Dopaminergic Neurochemical System.

Lee, Jae-Gyeong; Hur, Kwang-Hyun; Hwang, Su-Bin; Lee, Sooyeun; Lee, Seok-Yong; Jang, Choon-Gon

Lee, Jae-Gyeong; Hur, Kwang-Hyun; Hwang, Su-Bin; Lee, Sooyeun; Lee, Seok-Yong; Jang, Choon-Gon.

Afiliación

Lee JG; Department of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Hur KH; Department of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Hwang SB; Department of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Lee S; Department of Analytical Toxicology, College of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
Lee SY; Department of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Jang CG; Department of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.

ACS Chem Neurosci ; 14(15): 2658-2666, 2023 08 02.

Article en En | MEDLINE | ID: mdl-37463338

Asunto(s)

Drogas de Diseño; Alucinógenos; Ratas; Ratones; Animales; Drogas de Diseño/farmacología; Dopamina/metabolismo; Recompensa; Alucinógenos/metabolismo; Núcleo Accumbens/metabolismo

Palabras clave

25D-NBOMe; CPP; NBOMe; addiction; dopamine; self-administration

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Drogas de Diseño / Alucinógenos Idioma: En Revista: ACS Chem Neurosci Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Drogas de Diseño / Alucinógenos Idioma: En Revista: ACS Chem Neurosci Año: 2023 Tipo del documento: Article